Is there a role of MMA T wave alternans test for risk assessment in Brugada syndrome?

References (1)

1. Antzelevitch C, Brugada P Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005; 111: 659-70. [CrossRef] 2. Meregalli PG, Wilde AA, Tan HL. Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more? Cardiovasc Res 2005;67: 367-78. [CrossRef] 3. Delise P Allocca G, Marras E, Giustetto C, Gaita F, Sciarra L, et al. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J 2011; 32: 169-76. [CrossRef] 4. Raju H, Papadakis M, Govindan M, Bastiaenen R, Chandra N, O’Sullivan A, et al. Low prevelance of risk markers in cases of sudden death due to Brugada Syndrome relevance to risk stratification in Brugada syndrome. J Am Coll Cardiol 2011; 57: 2340-5. [CrossRef] 5. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P Brignole M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST- segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000; 102: 2509-15. [CrossRef] 6. Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 2008;118: 2022-8. [CrossRef] 7. Cox V, Patel M, Kim J, Liu T, Sivaraman G, Narayan SM. Predicting arrhythmia-free survival using spectral and modified moving average analysis of T-wave alternans. Pacing Clin Electrophysiol 2007; 30: 352-8. [CrossRef] 8. Nishizaki M, Fujii H, Sakurada H, Kimura A, Hiraoka M. Spontaneous T wave alternans in a patient with Brugada syndrome-responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing. J Cardiovasc Electrophysiol 2005; 16: 217-20. [CrossRef] 9. Fish JM, Antzelevich C. Cellular mechanism and arrhythmogenic potential of Twave alternans in the Brugada syndrome. J Cardiovasc Electrophysiol 2008; 19: 301-8. [CrossRef] 10. Nieminen T, Lehtimaki T, Viik J, Lehtinen R, Nikus K, Kööbi T, et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur Heart J 2007; 28